Healthtech Startup CribMD Acquires Charisland Pharmaceuticals

CribMD, a healthtech startup, has announced the acquisition of Charisland Pharmaceuticals Group to ensure that its patients in Nigeria receive fast and efficient one-hour drug deliveries.

CribMD’s acquisition of the pharmaceutical chain, rather than constructing a solution in-house, will allow it to take advantage of its huge network of pharmacies to supply prescriptions to subscribers faster. As part of the sale, the startup would be assimilating Charisland Pharmaceuticals Group’s staff and hiring more to build out its operations.